EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Myocardial inflammation in myocarditis: mechanisms and therapeutic targets

Cristina Madaudo, Daniela Di Lisi, Francesca Macaione, Vincenzo Nuzzi, Andrea Micarelli, Giusy Sausa, Giovanni Castelli, Egle Corrado, Alfredo Ruggero Galassi, Giuseppina Novo

Frontiers in Cardiovascular Medicine · 23.06.2026 · 13

DOI: 10.3389/fcvm.2026.1821475 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Frontiers in Cardiovascular Medicine, online erschienen am 23.06.2026. Verfasst von Cristina Madaudo und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Health Promotion, Mother and Child Care, Internal Medicine and Medical Specialties (ProMISE), University of Palermo, Palermo, Italy. Die Arbeit nennt 60 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Myocarditis is an inflammatory disease of the myocardium with heterogeneous aetiologies, in which innate and adaptive immune responses critically influence clinical outcomes, ranging from complete recovery to progression toward dilated cardiomyopathy. In viral myocarditis, pathogen- and damage-associated molecular patterns activate pattern-recognition receptors, triggering NF- κ B and inflammasome signaling and amplifying pro-inflammatory cytokine responses. Early myocardial injury involves neutrophils, mast cells, natural killer cells, and inflammatory monocytes, followed by activation of adaptive immune responses. Imbalance of Th1/Th2 immunity and dysregulation of the Th17/Treg axis promote persistent inflammation and fibrotic remodeling. Autoimmune mechanisms driven by molecular mimicry, pathogenic autoantibodies, and genetic susceptibility further sustain myocardial injury. While conventional biomarkers support diagnosis, emerging inflammatory markers and immune-derived indices show promise for risk stratification and disease monitoring. Beyond guideline-directed heart failure therapy, targeted immunomodulatory strategies are under investigation, highlighting the need for precision approaches to prevent chronic inflammation and adverse remodeling.

Schlagwörter

Stichwörter der Autor:innen

immunomodulatory therapyinflammationinflammation-guided risk stratificationinnate and adaptive immunitymyocarditis

Autor:innen und Institutionen

  • Department of Health Promotion, Mother and Child Care, Internal Medicine and Medical Specialties (ProMISE), University of Palermo, Palermo, Italy.
  • Division of Cardiology, University Hospital P. Giaccone, University of Palermo, Palermo, Italy.
  • Department of Clinical Cardiology and Heart Failure, Mediterranean Institute for Transplantation and Advanced Specialized Therapies, IRCCS ISMETT, UPMC, Palermo, Italy.

Zitieren

APA

Madaudo, C., Di Lisi, D., Macaione, F., Nuzzi, V., Micarelli, A., Sausa, G., Castelli, G., Corrado, E., Galassi, A. R., & Novo, G. (2026). Myocardial inflammation in myocarditis: mechanisms and therapeutic targets. Frontiers in Cardiovascular Medicine, 13. https://doi.org/10.3389/fcvm.2026.1821475

Vancouver

Madaudo C, Di Lisi D, Macaione F, Nuzzi V, Micarelli A, Sausa G, et al. Myocardial inflammation in myocarditis: mechanisms and therapeutic targets. Frontiers in Cardiovascular Medicine. 2026;13. doi:10.3389/fcvm.2026.1821475

BibTeX
@article{Madaudo2026,
  author = {Madaudo, Cristina and Di Lisi, Daniela and Macaione, Francesca and Nuzzi, Vincenzo and Micarelli, Andrea and Sausa, Giusy and Castelli, Giovanni and Corrado, Egle and Galassi, Alfredo Ruggero and Novo, Giuseppina},
  title = {Myocardial inflammation in myocarditis: mechanisms and therapeutic targets},
  journal = {Frontiers in Cardiovascular Medicine},
  year = {2026},
  volume = {13},
  doi = {10.3389/fcvm.2026.1821475}
}
Kostenlos starten →